What Is SoftWave Therapy?

SoftWave therapy is an advanced form of extracorporeal shockwave therapy (ESWT) that uses broadly focused acoustic waves to stimulate healing in injured tissue. Unlike traditional treatments that mask pain, SoftWave targets the underlying biology of injury, activating your body’s natural repair processes.

Shockwaves are high-energy acoustic waves that travel through tissue and deliver mechanical energy deep into muscles, tendons, ligaments, and joints. Learn more about shockwave here.

What Makes SoftWave Different?

Not all shockwave therapies are the same. Traditional systems fall into two categories:

• Radial shockwave (RSWT): Superficial, lower energy
• Focused shockwave (FSWT): Deeper, more targeted

Softwave uses an electrohydraulic shockwave, one of three established methods for generating focused extracorporeal shockwave therapy (ESWT), alongside electromagnetic and piezoelectric generation. All three methods produce clinically effective shockwaves for musculoskeletal conditions.

Electrohydraulic generation uses a high-voltage electrical discharge between two underwater electrodes, creating a plasma that reaches thousands of degrees Kelvin and generates a compressive pressure pulse (Cathignol et al, 1991).

This method was the original technology used for kidney stone lithotripsy and has since been adapted for musculoskeletal applications (d'Agostino et al, 2015; Thiel, 2001).

SoftWave uses this electrohydraulic energy to create a “broadly focused shockwave” delivered through a patented parabolic reflector. This unique geometry produces parallel shockwaves that travel across a wide activation zone, rather than converging at a small focal point or dispersing superficially. This combines advantages of both:

• Treats larger tissue areas
• Reaches clinically meaningful depth
• Delivers consistent energy distribution
• Avoids excessive focal tissue damage

This allows treatment of complex conditions like tendinopathy, joint degeneration, and chronic pain syndromes more effectively.

Mechanotransduction: The Core Biologic Mechanism

At the heart of SoftWave therapy is a concept called mechanotransduction. Mechanical energy generated from shockwaves is converted into biological signals through cellular membrane deformation, ion channel activation, ATP release, and gene expression pathways (Cheng & Wang, 2015; Mittermayr et al, 2021; d'Agostino et al, 2015).

Extracorporeal shockwave therapy functions as a form of "mechanotherapy" where the mechanisms of action are not related to direct mechanical tissue disruption (as in lithotripsy), but rather to biological reactions triggered through mechanotransduction (d'Agostino et al, 2015). The rapid pressure changes created by shockwaves generate mechanical stimuli that promote biological healing processes including tissue regeneration, angiogenesis, bone remodeling, and anti-inflammation (Cheng & Wang, 2015).

Shockwaves create rapid pressure changes in tissue, triggering:

• Cellular membrane deformation: Shockwaves create rapid pressure changes that cause cellular membrane deformation and activate mechanosensors on cell membranes. Research demonstrates that shockwaves activate mechanosensors including caveolin-1 and β1-integrin, which are essential for triggering downstream signaling cascades (Hatanaka et al, 2016).
• Ion channel activation: Shockwaves also activate stretch-activated calcium channels in cell membranes, leading to intracellular calcium increases through mechanosensing rather than membrane disruption (sonoporation). The calcium influx occurs through these channels and is amplified by calcium release through the PLC-IP3-IP3R cascade, with actin cytoskeletons playing a key role in this process (Takahashi et al, 2019).
• Release of signaling molecules (like ATP): ATP release is a central mechanism by which shockwaves initiate biological effects. Shockwave treatment triggers energy- and pulse number-dependent ATP release from cells, which serves as a key trigger for downstream biological effects (Weihs et al, 2014).
• Activation of gene expression pathways: Shockwave induced mechanotransduction activates multiple intracellular signaling cascades that drive gene expression (Weihs et al, 2014; Yu et al, 2010; Hatanaka et al, 2016; Basoli et al, 2020; Holfeld et al, 2016; Sun et al, 2013; Szwarc-Hofbauer et al, 2025).

These signals ultimately drive healing. These mechanotransduction mechanisms explain how shockwave therapy promotes tissue healing without causing significant tissue damage. The biological effects are dose-dependent, with energy levels and pulse numbers determining the magnitude of ATP release and subsequent cellular responses.

Step-by-Step: What Happens When SoftWave Hits Tissue

The biological responses described—stem cell activation, growth factor release (VEGF, TGF-β, IGF-1), and collagen production—are well-supported by peer-reviewed research as key regenerative effects of shockwave therapy (d'Agostino et al, 2015; Vetrano et al, 2011; Russo et al, 2015; Chen et al, 2004; Kou et al, 2024).

1. Physical Phase: Mechanical Energy Delivery

Shockwaves create rapid pressure spikes followed by negative pressure, producing:

• Micro-mechanical stress
• Tissue interface disruption
• Cavitation (tiny bubble formation and collapse)

This initiates the healing cascade.

2. Cellular Activation

The mechanical stimulus causes cells to release ATP and signaling molecules, activating pathways like:

• ERK / MAPK signaling
• PI3K / Akt pathways
• Calcium signaling

These pathways regulate:

• Cell proliferation
• Tissue repair
• Anti-inflammatory responses

3. Biological Response

This leads to several key regenerative effects:

Stem Cell Activation

Shockwave therapy recruits and activates local progenitor cells, enhancing tissue repair.

Growth Factor Release

Increased expression of:

• VEGF (vascular growth)
• TGF-β (tissue remodeling)
• IGF-1 (cell growth)

Collagen Production

Stimulates Type I collagen synthesis, critical for tendon healing.

Why Broadly Focused Shockwave Matters

The advantage of SoftWave’s broader energy field is that it:

• Treats entire injured regions, not just a pinpoint
• Addresses multifactorial pathology (tendon + fascia + nerve)
• Reduces risk of missing the true pain generator

In real-world musculoskeletal conditions, pain is rarely isolated to a single structure—this matters clinically.

Is SoftWave Just “Breaking Up Tissue”?

No—and this is a major misconception.

While early shockwave use focused on breaking calcifications, modern SoftWave therapy is about:

Cellular signaling and regeneration—not destruction

In fact, most of its benefits come from biological stimulation, not mechanical disruption.

What to Expect from Treatment

• Typically 3–6 sessions
• Each session lasts 10–15 minutes
• Minimal downtime
• Gradual improvement over weeks

Unlike injections, results are progressive, reflecting true tissue healing.

The Bottom Line

SoftWave therapy represents a shift in how we treat musculoskeletal injuries.

Instead of suppressing symptoms, it:

• Activates your body’s natural healing pathways
• Improves blood flow and tissue regeneration
• Reduces inflammation and pain at the source

By leveraging broadly focused shockwave technology, SoftWave provides a powerful, non-invasive solution for patients seeking long-term recovery, not temporary relief.

(781) 591-7855

info@BSBortho.com

20 Walnut St

Suite 14

Wellesley MA 02481

References

Basoli V, Chaudary S, Cruciani S, Santaniello S, Balzano F, Ventura C, Redl H, Dungel P, Maioli M. Mechanical Stimulation of Fibroblasts by Extracorporeal Shock Waves: Modulation of Cell Activation and Proliferation Through a Transient Proinflammatory Milieu. Cell Transplant. 2020 Jan-Dec;29:963689720916175. doi: 10.1177/0963689720916175. PMID: 32326741; PMCID:PMC7586264.

Cathignol D, Mestas JL, Gomez F, Lenz P. Influence of water conductivity on the efficiency and the reproducibility of electrohydraulic shock wave generation. Ultrasound Med Biol. 1991;17(8):819-28. doi: 10.1016/0301-5629(91)90165-s. PMID: 1808800.

Cheng JH, Wang CJ. Biological mechanism of shockwave in bone. Int J Surg. 2015 Dec;24(Pt B):143-6. doi: 10.1016/j.ijsu.2015.06.059. Epub 2015 Jun 25. PMID: 26118613.

Chen YJ, Wurtz T, Wang CJ, Kuo YR, Yang KD, Huang HC, Wang FS.
Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res. 2004 May;22(3):526-34. doi: 10.1016/j.orthres.2003.10.005. PMID: 15099631.

d'Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: From mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg. 2015 Dec;24(Pt B):147-53. doi: 10.1016/j.ijsu.2015.11.030. Epub 2015 Nov 28. PMID: 26612525.

Hatanaka K, Ito K, Shindo T, Kagaya Y, Ogata T, Eguchi K, Kurosawa R, Shimokawa H. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction. Am J Physiol Cell Physiol. 2016 Sep 1;311(3):C378-85. doi: 10.1152/ajpcell.00152.2016. Epub 2016 Jul 13. PMID: 27413171.

Holfeld J, Tepeköylü C, Reissig C, Lobenwein D, Scheller B, Kirchmair E, Kozaryn R, Albrecht-Schgoer K, Krapf C, Zins K, Urbschat A, Zacharowski K, Grimm M, Kirchmair R, Paulus P. Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle. Cardiovasc Res. 2016 Feb 1;109(2):331-43. doi: 10.1093/cvr/cvv272. Epub 2015 Dec 16. PMID: 26676850.

Kou D, Chen Q, Wang Y, Xu G, Lei M, Tang X, Ni H, Zhang F. The application of extracorporeal shock wave therapy on stem cells therapy to treat various diseases. Stem Cell Res Ther. 2024 Aug 26;15(1):271. doi: 10.1186/s13287-024-03888-w. PMID: 39183302;PMCID: PMC11346138.

Mittermayr R, Haffner N, Feichtinger X, Schaden W. The role of shockwaves in the enhancement of bone repair - from basic principles to clinical application. Injury. 2021 Jun;52 Suppl 2:S84-S90. doi: 10.1016/j.injury.2021.02.081. Epub 2021 Mar 2. PMID: 33714550.

Rosso F, Bonasia DE, Marmotti A, Cottino U, Rossi R. Mechanical
Stimulation (Pulsed Electromagnetic Fields "PEMF" and Extracorporeal Shock Wave Therapy "ESWT") and Tendon Regeneration: A Possible Alternative. Front Aging Neurosci. 2015 Nov 9;7:211. doi: 10.3389/fnagi.2015.00211. PMID: 26617513; PMCID: PMC4637423.

Sun D, Junger WG, Yuan C, Zhang W, Bao Y, Qin D, Wang C, Tan L, Qi B, Zhu D, Zhang X, Yu T. Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors. Stem Cells. 2013 Jun;31(6):1170-80. doi: 10.1002/stem.1356. PMID: 23404811; PMCID: PMC4243484.

Szwarc-Hofbauer D, Simböck E, Hromada C, Stoiber M, Tomasch J, Weitzer G, Teuschl-Woller A. Purinergic receptors play a key role in shock wave-induced proliferation. Sci Rep. 2025 May 31;15(1):19138. doi: 10.1038/s41598-025-02955-3. PMID:40450090; PMCID: PMC12126489.

Takahashi T, Nakagawa K, Tada S, Tsukamoto A. Low-energy shock waves evoke intracellular Ca²⁺ increases independently of sonoporation. Sci Rep. 2019 Mar 1;9(1):3218. doi: 10.1038/s41598-019-39806-x. PMID: 30824781; PMCID: PMC6397190.

Thiel M. Application of shock waves in medicine. Clin Orthop Relat Res. 2001 Jun;(387):18-21. doi: 10.1097/00003086-200106000-00004. PMID: 11400881.

Vetrano M, d'Alessandro F, Torrisi MR, Ferretti A, Vulpiani MC, Visco V. Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes. Knee Surg Sports Traumatol Arthrosc. 2011 Dec;19(12):2159-68. doi: 10.1007/s00167-011-1534-9. Epub 2011 May 27. PMID: 21617986.

Weihs AM, Fuchs C, Teuschl AH, Hartinger J, Slezak P, Mittermayr R, Redl H, Junger WG, Sitte HH, Rünzler D. Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 2014 Sep 26;289(39):27090-27104. doi: 10.1074/jbc.M114.580936. Epub 2014 Aug 12. PMID: 25118288; PMCID: PMC4175346.

Yu T, Junger WG, Yuan C, Jin A, Zhao Y, Zheng X, Zeng Y, Liu J.
Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation. Am J Physiol Cell Physiol. 2010 Mar;298(3):C457-64. doi: 10.1152/ajpcell.00342.2009. Epub 2009 Nov 4. PMID: 19889958; PMCID: PMC4631534.